Low blood sugar, medically known as hypoglycemia, is a condition that occurs when the glucose levels in your blood drop below ...

RIZE enrollment on track including U.S. sites and expected to be completed in May 2025; topline data anticipated in December 2025 U.S. Food and Drug Administration (FDA) grants Breakthrough Therapy ...

The Marketing Authorization Application (MAA) for Day One Biopharmaceuticals and Ipsen’s tovorafenib was accepted for review ...

People with type 2 diabetes don’t make an adequate amount of insulin to manage their blood sugar. Stem cell therapy may ...

High blood sugars have long been known to cause eye damage in diabetics. However, new research has found that low blood sugar ...

At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals First Quarter Earnings Conference Call. All participants will be in a listen-only mode. After today’s presentation there ...

Nutritional counseling remains a central component of obesity treatment, even in the era of highly effective weight-loss ...

Earlier this year, the Company announced that BTD was granted to ersodetug for the treatment of hypoglycemia caused by congenital HI, a separate late-stage program currently progressing in an ongoing ...

Earlier this year, the Company announced that BTD was granted to ersodetug for the treatment of hypoglycemia caused by congenital HI, a separate late-stage program currently progressing in an ...